We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AULSF market cap is 2.56M. The company's latest EPS is CNY -0.2214 and P/E is 0.00.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 1.05B | 1.3B | 2.02B | 2.23B | 1.81B |
| Operating Income | 15.2M | 46.39M | 132.02M | 99.93M | -52.78M |
| Net Income | 8.09M | 33.1M | 277.3M | 87.46M | -113.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 1.17B | 1.38B | 2.04B | 2.39B | 2.16B |
| Total Liabilities | 671.7M | 854.27M | 1.26B | 1.51B | 1.38B |
| Total Equity | 502.63M | 524.57M | 788.42M | 883.58M | 775.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 37.79M | 52.22M | -103.45M | -37.93M | -62.65M |
| Investing | -22.09M | -59.81M | 65.02M | -153.14M | -54.47M |
| Financing | -20.69M | -5.51M | 59.35M | 125.3M | 147.12M |
| Market Cap | 2.56M |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 512.58M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -99.74% |
| 52 Week High | 2.10 |
| 52 Week Low | 0.0007 |
| Spread (Intraday) | 1.3 (99.93%) |
| Company Name | Austar Lifesciences Ltd (PK) |
| Address |
cricket square, hutchins drive grand cayman KY1-1111 |
| Website | https://www.austar.com.hk |
| Industry | meats and meat products-whsl (5147) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
